Mar 4 |
Akoya Biosciences (AKYA) Reports Q4 Loss, Tops Revenue Estimates
|
Mar 4 |
Recap: Akoya Biosciences Q4 Earnings
|
Mar 4 |
Akoya Biosciences GAAP EPS of -$0.22 beats by $0.06, revenue of $26.5M beats by $0.39M
|
Mar 4 |
Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook
|
Mar 4 |
Earnings Scheduled For March 4, 2024
|
Feb 24 |
Akoya Biosciences Insiders Placed Bullish Bets Worth US$2.11m
|
Feb 13 |
Are Medical Stocks Lagging Aclaris Therapeutics (ACRS) This Year?
|
Jan 31 |
Bristol Myers' (BMY) sBLAs for Breyanzi Get FDA Priority Tag
|
Jan 26 |
Is Abbott Laboratories (ABT) Stock Outpacing Its Medical Peers This Year?
|
Jan 14 |
Akoya Biosciences, Inc.'s (NASDAQ:AKYA) market cap touched US$254m last week, benefiting both private equity firms who own 48% as well as institutions
|